Biochem/physiol Actions
PD-184161 is a MEK inhibitor.
Features and Benefits
This compound is featured on the MAPKKKs page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Other Notes
This compound was developed by Pfizer for Kinase Phosphatase Biology research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.
To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Pfizer is a registered trademark of Pfizer, Inc.
- UPC:
- 42181902
- Condition:
- New
- HazmatClass:
- No
- MPN:
- PZ0112-25MG
- CAS:
- 212631-67-9
akash.verma@cenmed.com
(732) 447-1115





